Cetera Investment Advisers
MBIO icon

Cetera Investment Advisers’s Mustang Bio MBIO Stock Holding History

Cetera Investment Advisers’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16
Closed -$7K – 1826
2022
Q2 		$7K Buy
16
+1
+7% +$554 ﹤0.01% 1803
2022
Q1 		$12K Buy
+15
New +$12.3K ﹤0.01% 1850

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cetera Investment Advisers's MBIO Position: Q3 2022 in Review

Cetera Investment Advisers sold out of Mustang Bio (MBIO) in Q3 2022, closing a stake of 16 shares — an estimated $7K sold.

Cetera Investment Advisers first reported a position in MBIO in Q1 2022 and held it in 2 quarters. The position peaked at $12K in Q1 2022. 67 funds tracked by Wall St. Rank hold MBIO as of Q3 2022.

  • Cetera Investment Advisers reported no remaining Mustang Bio position as of Q3 2022 after selling out during the quarter.
  • Cetera Investment Advisers sold 16 Mustang Bio shares in Q3 2022, an estimated $7K.
  • Cetera Investment Advisers first reported a position in Mustang Bio in Q1 2022 and held it in 2 quarters.
  • Cetera Investment Advisers's Mustang Bio position peaked at $12K in Q1 2022.
  • 67 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2022.

Based on Cetera Investment Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.